Schedule 13G ownership disclosure

CONSTELLATION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 210373106

Event date: 2018-07-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,740,945
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-049177
Form type
SC 13G
Filer
CONSTELLATION PHARMACEUTICALS INC
CIK
CIK 1434418
Filed
Aug 02, 2018
Reporting period
Jul 23, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub